Prognostic associations of prostate-specific antigen (PSA) decline with survival, radiographic response and progression in chemotherapy-naiive men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide
Publication
, Conference
Armstrong, AJ; Lin, P; Higano, CS; Iversen, P; Sternberg, CN; Tombal, B; Phung, D; Parli, T; Krivoshik, A; Beer, TM
Published in: ANNALS OF ONCOLOGY
September 1, 2017
Duke Scholars
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
September 1, 2017
Volume
28
Location
Madrid, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
42nd European-Society-for-Medical-Oncology Congress (ESMO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Lin, P., Higano, C. S., Iversen, P., Sternberg, C. N., Tombal, B., … Beer, T. M. (2017). Prognostic associations of prostate-specific antigen (PSA) decline with survival, radiographic response and progression in chemotherapy-naiive men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide. In ANNALS OF ONCOLOGY (Vol. 28). Madrid, SPAIN: OXFORD UNIV PRESS.
Armstrong, A. J., P. Lin, C. S. Higano, P. Iversen, C. N. Sternberg, B. Tombal, D. Phung, T. Parli, A. Krivoshik, and T. M. Beer. “Prognostic associations of prostate-specific antigen (PSA) decline with survival, radiographic response and progression in chemotherapy-naiive men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.” In ANNALS OF ONCOLOGY, Vol. 28. OXFORD UNIV PRESS, 2017.
Armstrong AJ, Lin P, Higano CS, Iversen P, Sternberg CN, Tombal B, et al. Prognostic associations of prostate-specific antigen (PSA) decline with survival, radiographic response and progression in chemotherapy-naiive men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2017.
Armstrong, A. J., et al. “Prognostic associations of prostate-specific antigen (PSA) decline with survival, radiographic response and progression in chemotherapy-naiive men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.” ANNALS OF ONCOLOGY, vol. 28, OXFORD UNIV PRESS, 2017.
Armstrong AJ, Lin P, Higano CS, Iversen P, Sternberg CN, Tombal B, Phung D, Parli T, Krivoshik A, Beer TM. Prognostic associations of prostate-specific antigen (PSA) decline with survival, radiographic response and progression in chemotherapy-naiive men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2017.
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
September 1, 2017
Volume
28
Location
Madrid, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
42nd European-Society-for-Medical-Oncology Congress (ESMO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis